SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-014575
Filing Date
2021-04-27
Accepted
2021-04-27 16:34:53
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10023195x2_defa14a.htm DEFA14A 19136
2 nc10023195x2_nc01.jpg GRAPHIC 742465
3 nc10023195x2_nc02.jpg GRAPHIC 482762
  Complete submission text file 0001140361-21-014575.txt   1708329
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-32302 | Film No.: 21859496
SIC: 3841 Surgical & Medical Instruments & Apparatus
Office of Life Sciences